US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022

Publisher Name :
Date: 03-Nov-2017
No. of pages: 86
Inquire Before Buying

“The US anticoagulation therapy market projected to grow at a CAGR of 8.5%.”

The US anticoagulation therapy market is projected to reach USD 27.83 billion by 2022 from an estimated USD 18.49 billion in 2017, at a CAGR of 8.5%. The US anticoagulation therapy market is segmented into products (anticoagulation drugs, PT/INR testing devices) and anticoagulation clinics. The growth of the anticoagulation drugs market is primarily driven by the rising incidence of venous thromboembolism, a trial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs). On the other hand, the high cost of NOACs and requirement of significant investments in the development of anticoagulation drugs are the major factors restraining the growth of this market. In addition, the growth of the anticoagulation clinics market is primarily driven by the increasing prevalence of cardiovascular diseases & blood disorders, high level of medication adherence associated with clinics, and rising aging population.

“The NOACs segment is expected to grow at the highest CAGR during the forecast period.”

The anticoagulation therapy market for drugs is categorized into NOACs, war far in (VKA), and other drugs. The NOACs segment is expected to grow at the highest CAGR during the forecast period. Due to the better safety and efficacy of NOACs, as compared to traditional therapies, the adoption of NOACs is higher as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC - Betrixaban in July 2017) are focusing on the development of NOACs in order to capitalize on the growth opportunities presented by this shift in market dynamics. Consequently, many other companies are also expected to focus on developing more safe and efficient NOACs in the coming years; this will ensure the continued growth of this segment.

“By type of clinics, the pharmacy-based anticoagulation clinics segment is expected to grow at the highest CAGR during the forecast period.”

On the basis of clinics type, the US anticoagulation therapy market for clinics market is categorized into hospitals associated clinics, independent clinics, and pharmacy-based clinics. The pharmacy-based clinics segment is expected to grow at the highest CAGR during the forecast period. In the US, the number of pharmacy-based anticoagulation clinics has increased significantly in the last few years. This due is to the fact that better results are achieved when therapy is managed by expert pharmacists rather than care provided by family physicians .Moreover, the cost of therapy provided by pharmacy-based anticoagulation clinics is comparatively lesser than independent and hospital associated anticoagulation clinics which is expected to drive the market for pharmacy-based anticoagulation clinics.

Break of primary participants was as mentioned below:


  • By Company Type – Tier 1–46%, Tier 2–36% and Tier 3–18%

  • By Designation – C-level–22%, Director Level–45%, Others–33%


Market players such as C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices.

Research Coverage:

The US anticoagulation therapy market in this report is segmented by products and clinics. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, and industry-specific opportunities). The study tracks and analyzes competitive developments (such as new product developments and R&D activities) and profiles the key players in the US anticoagulation therapy market.

Reasons to buy this report:

From an insight perspective, this research report has focused on various levels of analysis—market share of NOACs, company profiles, emerging and high-growth segments of the US anticoagulation therapy market; market drivers, restraints, and opportunities. The report provides the latest reimbursement trends for PT/INR testing, revenue structure, business models of anticoagulation clinics and in-depth impact analysis of NOACs on anticoagulation clinics, allowing buyers to identify the high growth product segment and potential customers and suppliers hence driving revenue growth and profitability.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on anticoagulation therapy solutions offered by the top players in the US anticoagulation therapy market

  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the US anticoagulation therapy market

  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the US anticoagulation therapy market

  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the US anticoagulation therapy market.

US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Data
2.1.2 Primary Data
2.1.2.1 Breakdown of Primary Interviews
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Market Sizing Methodology for Anticoagulation Drugs and PT/INR Testing Devices
2.2.2 Market Sizing Methodology for Anticoagulation Therapy for Clinics
2.2.3 Market Breakdown and Data Triangulation
2.2.4 Market Share Estimation
2.2.5 Assumptions for the Study

3 Market Overview
3.1 Market Dynamics: Anticoagulation Drugs
3.1.1 Drivers
3.1.1.1 Rising Incidence of Venous Thromboembolism, Atrial Fibrillation, and Stroke
3.1.1.2 Increasing Demand for Noacs as Alternatives to Warfarin
3.1.1.3 Growing Number of Patients Requiring Lifelong Anticoagulation Therapy
3.1.2 Market Restraints
3.1.2.1 High Price of Noacs
3.1.2.2 High Development Expenditure, Stringent Regulations
3.1.3 Market Opportunities
3.1.3.1 Increase in Outpatient Management of Anticoagulation Therapy
3.1.3.2 Development of Noac Reversal Agents
3.2 Market Dynamics: Anticoagulation Clinics
3.2.1 Key Market Drivers
3.2.1.1 Increasing Prevalence of Cvd and Blood Disorders
3.2.1.2 High Level of Medication Adherence
3.2.1.3 Growth in the Geriatric Population
3.2.2 Market Restraints
3.2.2.1 Rising Adoption of Noacs
3.2.2.2 Demand for Alternative Treatments
3.2.2.3 Home PT/INR Testing
3.2.3 Market Opportunities
3.2.3.1 Development of Alternative Approaches

4 Market Insights
4.1 Introduction
4.2 Number of Anticoagulation Clinics
4.3 Business Models of Anticoagulation Clinics
4.3.1 Revenue Structure
4.3.2 Infrastructure Requirements for Sustaining in the Market
4.3.2.1 Role of Teleconsultation and Telemonitoring
4.3.2.2 Role of Electronic Health Record in Anticoagulation Clinics
4.4 Reimbursement Scenario (CMS & Private Payers)
4.4.1 Reimbursement Rate (2016–2017)
4.4.1.1 Reimbursement for PT/INR Testing
4.4.1.2 Reimbursement for Evaluation and Management Service Associated With Anticoagulation Therapy
4.4.2 Reimbursement Trends for Anticoagulation Therapy
4.5 Impact of New Oral Anticoagulants (Noacs) on Anticoagulation Clinics

5 US Anticoagulation Therapy (Products) Market
5.1 US Anticoagulation Therapy (Products) Market for Drugs
5.1.1 Introduction
5.1.2 Novel Oral Anticoagulants
5.1.3 Warfarin (Vitamin K Antagonist)
5.1.4 Other Drugs
5.2 US Anticoagulation Therapy (Products) Market for PT/INR Testing Devices
5.2.1 Introduction
5.2.2 In-Office Testing Devices
5.2.3 Home Testing Devices

6 US Anticoagulation Therapy Market for Clinics
6.1 Introduction
6.2 US Anticoagulation Therapy Market for Clinics, By Type of Service
6.2.1 Introduction
6.2.2 Testing Services
6.2.3 Consulting Services
6.3 US Anticoagulant Therapy Market for Clinics, By Type of Clinic
6.3.1 Introduction
6.3.2 Hospital Associated Clinics
6.3.3 Independent Clinics
6.3.4 Pharmacy-Based Clinics

7 Company Profiles
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
7.1 Introduction
7.2 Home Testing Devices Manufacturers
7.2.2 Abbott Laboratories
7.2.3 Siemens AG
7.2.4 Coagusense, Inc.
7.2.5 Alere Inc.
7.3 Drug Manufacturers
7.3.1 C. H. Boehringer Sohn AG & Co. Kg
7.3.2 Bristol-Myers Squibb Company
7.3.3 Johnson & Johnson
7.3.4 Pfizer, Inc.
7.3.5 Daiichi Sankyo Company, Limited
7.3.6 Portola Pharmaceuticals, Inc.

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

List of Tables

Table 1 Impact Analysis: Market Drivers
Table 2 Cost Difference: Noac vs Warfarin, Per Patient Per Month, in the US (2015)
Table 3 Impact Analysis: Market Restraints
Table 4 Pipeline Assessment: Anticoagulant Reversal Agents
Table 5 Impact Analysis: Market Opportunities
Table 6 Impact Analysis: Market Drivers
Table 7 Impact Analysis: Market Restraints
Table 8 Impact Analysis: Market Opportunities
Table 9 Component Cost for Different Treatment Settings of Anticoagulation Clinics
Table 10 Laboratory PT/INR Testing Reimbursement Codes & Rates
Table 11 Physician-Directed Home PT/INR Testing Hcpcs Reimbursement Codes & Rates (National)
Table 12 Physician-Directed Home PT/INR Testing Hcpcs Reimbursement Rates (State-Wise)
Table 13 Home PT/INR Testing Service Reimbursement Ambulatory Payment Classifications (Apcs) Codes & Rates Under Hospital Outpatient Prospective Payment System
Table 14 State Regulatory Bodies for PT/INR Test Reimbursement
Table 15 Reimbursement Rate for E&M Services During Anticoagulation Therapy (2015)
Table 16 Physician-Directed Home PT/INR Testing Hcpcs Reimbursement Codes & Rates, 2009 vs 2016 (National Rate)
Table 17 Laboratory PT/INR Testing Reimbursement Codes & Rates, 2009 vs 2016 (National Rate)
Table 18 Preliminary Payment Rates in 2018, 2019, and 2020 (With 10% Reduction Cap Wherever Applicable)
Table 19 Coagulation Assay Responsiveness to Noacs
Table 20 US Anticoagulation Therapy (Products) Market for Drugs, By Type, 2015–2022 (USD Million)
Table 21 List of Novel Oral Anticoagulants Available in the US Market
Table 22 Average Cost of Oral Anticoagulants Per Patient Per Month in the US (2015)
Table 23 US Anticoagulation Therapy (Products) Market for PT/INR Testing Devices, By Type, 2015–2022 (USD Million)
Table 24 US In-Office PT/INR Testing Devices Market, 2015–2022 (USD Million)
Table 25 Leading Home Testing Devices Available in the US Market
Table 26 Statistics of Thromboembolic Conditions in the Us
Table 27 US Anticoagulation Therapy Market for Clinics, By Type of Service, 2015–2022 (USD Million)
Table 28 Major Anticoagulation Clinics in the Us
Table 29 US Anticoagulant Therapy Market for Clinics, By Type of Clinic, 2015–2022 (USD Million)

List of Figures

Figure 1 US Anticoagulation Therapy Market Segmentation
Figure 2 Secondary Research Approach
Figure 3 Primary Research Approach
Figure 4 Market Sizing Approach
Figure 5 Data Triangulation Methodology
Figure 6 US Anticoagulation Drugs Market: Drivers, Restraints, and Opportunities
Figure 7 US Anticoagulation Therapy Market for Clinics: Drivers, Restraints & Opportunities
Figure 8 Number of Patient Visits to Anticoagulation Clinics, By Line of Therapy (2016 vs 2022)
Figure 9 Average Number/ Percentage Share of Noac Therapy Patients Visiting Anticoagulant Clinics, 2015 vs 2020
Figure 10 Evolution of Anticoagulants
Figure 11 Percentage of Anticoagulants Prescribed for Different Indications
Figure 12 Noacs, the Largest Segment in the US Anticoagulation Therapy (Products) Market for Drugs
Figure 13 In-Office Testing Devices, the Largest Segment in the US Anticoagulation Therapy (Products) Market for PT/INR Testing Devices
Figure 14 Testing Services to Dominate the global Market for Clinics in 2017
Figure 15 Hospital-Associated Clinics Segment Will Continue to Dominate the US Anticoagulation Therapy Market for Clinics in 2022
Figure 16 F. Hoffmann-La Roche AG: Company Snapshot (2016)
Figure 17 Abbott Laboratories: Company Snapshot (2016)
Figure 18 Siemens AG: Company Snapshot (2016)
Figure 19 Alere Inc.: Company Snapshot (2016)
Figure 20 C. H. Boehringer Sohn AG & Co. Kg: Company Snapshot (2016)
Figure 21 Bristol-Myers Squibb Company: Company Snapshot (2016)
Figure 22 Johnson & Johnson: Company Snapshot (2016)
Figure 23 Pfizer, Inc.: Company Snapshot (2016)
Figure 24 Daiichi Sankyo Company, Limited: Company Snapshot (2015)
Figure 25 Portola Pharmaceuticals, Inc.: Company Snapshot (2016)

  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs